Sign up to save your podcasts
Or
Share Pyruvate Kinase (PK) Deficiency Highlights from ASH 2021
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pyruvate Kinase (PK) Deficiency Highlights from ASH 2021
This accredited CME activity, led by Rachael Grace, MD, Associate Professor, Harvard Medical School, highlights the latest research about pyruvate kinase (PK) deficiency presented at ASH 2021 and provides expert analysis of its clinical relevance for busy members of the care team to help them care for patients they may encounter with this rare condition.
PK deficiency is a rare blood disease due to mutations in the PKLR gene that leads to decreased PK levels. Current therapies options are supportive (transfusions, iron chelation, splenectomy) but treatments are in development to better address the pathophysiology of this rare condition.
Supported by an educational grant from Agios Pharmaceuticals.
To obtain CME credit, please go to https://checkrare.com/learning-center/courses/
PK deficiency is a rare blood disease due to mutations in the PKLR gene that leads to decreased PK levels. Current therapies options are supportive (transfusions, iron chelation, splenectomy) but treatments are in development to better address the pathophysiology of this rare condition.
Supported by an educational grant from Agios Pharmaceuticals.
To obtain CME credit, please go to https://checkrare.com/learning-center/courses/
View all episodes
By Peter Ciszewski, CheckRare
5
33 ratings
This accredited CME activity, led by Rachael Grace, MD, Associate Professor, Harvard Medical School, highlights the latest research about pyruvate kinase (PK) deficiency presented at ASH 2021 and provides expert analysis of its clinical relevance for busy members of the care team to help them care for patients they may encounter with this rare condition.
PK deficiency is a rare blood disease due to mutations in the PKLR gene that leads to decreased PK levels. Current therapies options are supportive (transfusions, iron chelation, splenectomy) but treatments are in development to better address the pathophysiology of this rare condition.
Supported by an educational grant from Agios Pharmaceuticals.
To obtain CME credit, please go to https://checkrare.com/learning-center/courses/
PK deficiency is a rare blood disease due to mutations in the PKLR gene that leads to decreased PK levels. Current therapies options are supportive (transfusions, iron chelation, splenectomy) but treatments are in development to better address the pathophysiology of this rare condition.
Supported by an educational grant from Agios Pharmaceuticals.
To obtain CME credit, please go to https://checkrare.com/learning-center/courses/